Download presentation
Presentation is loading. Please wait.
Published byKirk Binner Modified over 9 years ago
1
Sociedade Portuguesa de Inovação Brussels, February 2006 Overview of Recent Collaborative Efforts between the European and the Chinese Research Communities
2
ChinaFrontier: China’s Realities from a Frontier Research Perspective February 2006 Index Introduction Framework Programme 5 (1998-2002) Framework Programme 6 (2002-2006) Framework Programme 7 (2006-2013) Recent Collaborative Efforts between Europe and P.R. China
3
ChinaFrontier: China’s Realities from a Frontier Research Perspective February 2006 Opportunities for International Collaborations in the Framework Programmes Introduction Research activities of the European Union are designed to stimulate collaboration between European countries. Thanks to the EU-China Science & Technology agreement, Chinese research organisations can participate in EU projects. Chinese partners can be supported by either the European Commission or the Chinese Ministry of Science and Technology. European research organisations are supported by the European Commission.
4
ChinaFrontier: China’s Realities from a Frontier Research Perspective February 2006 Rules for Participation in FP5 Proposal Consortia Framework Programme 5 Calls were open to participation by entities from non-EU countries and to international organisations. Third country/international organisation had to be included as a participant in the original proposal submitted. Third States could participate without Community Funding (exceptionally with Community funding when duly justified as being essential for achieving the objectives of the project).
5
ChinaFrontier: China’s Realities from a Frontier Research Perspective February 2006 Research Areas and Research Activities Eligible for Funding Under FP6 Framework Programme 6 Thematic areas / priorities Strengthening the foundations of ERA Structuring the ERA Cross-cutting Research activities Nuclear Energy
6
ChinaFrontier: China’s Realities from a Frontier Research Perspective February 2006 Most Prominent Opportunities for International Participation in FP6 Proposal Consortia Framework Programme 6 Thematic areas / priorities: Life sciences, genomics and biotechnology for health Information Society Technologies (IST Programme) Nanotechnology and nanosciences, knowledge-based multifunctional materials and new production processes and devices (NMP) Aeronautics and Space Food Quality and Safety Sustainable development, global change and ecosystems Citizens and Governance in a Knowledge-Based Society
7
ChinaFrontier: China’s Realities from a Frontier Research Perspective February 2006 Most Prominent Opportunities for International Participation in FP6 Proposal Consortia Framework Programme 6 Cross-cutting activities: New and Emerging Science and Technology (NEST Programme) SME activities JRC activities Research for Policy Support International Cooperation (INCO Programme)
8
ChinaFrontier: China’s Realities from a Frontier Research Perspective February 2006 Rules for participation in FP6 proposal consortia Framework Programme 6 All legal entities established in a third country which has concluded a scientific and technological cooperation agreement with the Community (e.g. P.R. China) may take part in RTD activities in accordance with the conditions stipulated in that agreement All legal entities may receive a Community financial contribution if provision is made for this under an RTD activity or if it is essential for carrying out the indirect action.
9
ChinaFrontier: China’s Realities from a Frontier Research Perspective February 2006 Framework Programme 7 Research Areas Eligible for Funding under FP7 (Four Specific Programmes) Cooperation Collaborative Research Ideas Frontier Research People Human Potential Capacities Research Capacity
10
ChinaFrontier: China’s Realities from a Frontier Research Perspective February 2006 Framework Programme 7 Where International Partners may Fit in FP7 Cooperation Collaborative Research (e.g. 9 Thematic Priority Calls – Coordination Actions; Support Actions) Ideas Frontier Research (e.g ERA) People Human Potential (e.g. Marie Curie Actions – Training Mobility) Capacities Research Capacity (e.g. INCO initiatives)
11
ChinaFrontier: China’s Realities from a Frontier Research Perspective February 2006 Rules for Participation in FP7 Proposal Consortia Framework Programme 7 In line with the objectives of international cooperation the participation of legal entities established in third countries (e.g. P.R. China) should be envisaged, as should the participation of international organisations. Such participation shall be justified in terms of the enhanced contribution thereby made to the objectives sought under the Seventh Framework Programme.
12
ChinaFrontier: China’s Realities from a Frontier Research Perspective February 2006 Recent Collaborative Efforts between Europe and P.R. China InnoChina Project (FP5 INCO-A5) – Mr. Mark Spinoglio (SPI - Portugal) Hypodermosis Control (FP5 INCO 2) – Dr. Chantal Boulard (INRA - France) PROBACTYS Project (NEST – FP6) – Dr. Vítor Santos (GBF - Germany) SOYBEAN BNF+MYC Project (INCO-FP6) – Prof. Dietrich Werner (University Marburg – Germany) DYSONET Project (NEST-FP6) – Prof. Panos Argyrakis (Aristotle University of Thessaloniki)
13
ChinaFrontier: China’s Realities from a Frontier Research Perspective February 2006 Porto - Portugal Edificio “Les Palaces” Rua Júlio Dinis, no. 242, 208 4050-318 Porto, PORTUGAL Tel: 22 607 64 00 Fax: 22 609 91 64 spiporto@spi.pt TagusPark Núcleo Central, 232 2780 - 920 Oeiras, PORTUGAL Tel: 21 421 22 49 Fax: 21 421 12 01 spilisboa@spi.pt Beijing – P.R.China China Garments Mansion, No. 915 Jianguo Rd., ChaoYang Dist. Beijing 100020 CHINA spichina@spi.pt California - USA 2102 Business Center Drive, Suite 220E Irvine, CA 92612 USA Tel: +1 949 253 5702 Fax: +1 949 253 5703 spiusa-irvine@usaspi.com Maryland - USA 5523 Research Park Drive, Suite 325 Baltimore, MD 21228 | USA Tel: +1 443 543-5530 Fax: +1 443 543-5533 info@usaspi.com Lisbon - Portugal www.spi.pt
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.